NEUROLOGISK KLINIK ApS: Financial statements 2019
CVR: 31748429
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
NEUROLOGISK KLINIK ApS (CVR 31748429) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 258,911 and a net result of DKK 144,705 compared with DKK 13,197 the year before. That is an increase of 190.6% compared with the year before. Equity in the 2019 report amounted to DKK 520,699. The solvency ratio was 58.4%.
- Gross Profit
- DKK 258,911
- Profit/Loss
- DKK 144,705
- Equity
- DKK 520,699
- Total Assets
- DKK 891,760
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 259K | 145K | 521K | - |
| 2018 | - | 89K | 13K | 376K | 0 |
| 2017 | - | 202K | 100K | 363K | 0 |
| 2016 | - | 112K | 30K | 262K | - |
| 2015 | - | 157K | 63K | 233K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
NEUROLOGISK KLINIK ApS has published its annual report for 2018. Gross profit came to DKK 89,099, and the net result was DKK 13,197.
About NEUROLOGISK KLINIK ApS
NEUROLOGISK KLINIK ApS was a Danish company of the type Anpartsselskab based in Langå, founded in 2008. The company has been dissolved on 19 December 2023. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SOMNOLEPSION BIOTECH ApS. The company has 0 employees (2020). In 2022, the company reported a gross profit of DKK 99,955 and a net result of DKK 265,911 compared with DKK 699,794 the year before. Equity in the 2022 report amounted to DKK 1,716,091.